Tenaya Therapeutics Inc (TNYA)

Finanzdaten der Tenaya Therapeutics Inc-Aktie (TNYA)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	393.33%1.11	0.23	-	-	-
	122.76%45.20	20.29	20.78	20.94	24.08
Research and Development	11.86%16.60	14.84	14.80	15.36	17.37
Depreciation and Amortization	5.56%1.70	1.80	1.80	1.90	2.10
Operating Income/Loss	119.73%-44.09	-20.07	-20.78	-20.94	-24.08
Nonoperating Income/Loss	12.36%0.70	0.79	0.60	0.66	0.80
Income/Loss From Continuing Operations Before Tax	125.16%-43.39	-19.27	-20.18	-20.28	-23.28
Income Tax Expense/Benefit	-	-	-	-	-
	125.16%-43.39	-19.27	-20.18	-20.28	-23.28
Attributable To Parent	125.16%-43.39	-19.27	-20.18	-20.28	-23.28
Basic Average Shares	0.32%217.57	216.88	-	163.35	162.79
Diluted Average Shares	0.32%217.57	216.88	-	163.35	162.79
Basic Earnings Per Share	122.22%-0.20	-0.09	-	-0.12	-0.14
Diluted Earnings Per Share	122.22%-0.20	-0.09	-	-0.12	-0.14